Amgen Inc. buy tamam
Start price
16.06.17
/
50%
€147.78
Target price
11.09.17
€164.89
Performance (%)
12.61%
End price
11.09.17
€165.38
Summary
This prediction ended on 11.09.17 with a price of €165.38. The prediction had a final performance of 12.61%. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Amgen Inc. | -1.948% | -1.948% | 39.279% | 44.106% |
iShares Core DAX® | -0.205% | 2.528% | 16.157% | 18.725% |
iShares Nasdaq 100 | 1.613% | 4.733% | 30.626% | 56.133% |
iShares Nikkei 225® | -0.740% | 0.396% | 9.039% | 5.948% |
iShares S&P 500 | 0.267% | 2.720% | 26.333% | 47.720% |
Comments by tamam for this prediction
In the thread Amgen Inc. diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 16.06.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 182.81$ zu.
(Zielkurs erreicht)